Today’s news

The Hidden Burden of Invasive Fungal Infections in Cancer Care Gains Greater Attention

Experts highlight the growing burden of invasive fungal infections among patients receiving cancer treatment. Immune suppression caused by chemotherapy and transplantation increases vulnerability to Aspergillus, Candida, and Mucorales, making early diagnosis, preventive antifungal therapy, and improved clinical awareness essential for reducing mortality and treatment-related complications.

View Post

mold news - Candida auris is spreading in the United States

View Post

Today’s news

Candida auris Cases Continue to Rise in the United States, Raising Concerns Over Drug Resistance and Healthcare Transmission

CDC surveillance shows Candida auris cases continue rising in the United States. The multidrug-resistant yeast spreads primarily in healthcare settings, survives on surfaces for weeks, and increasingly challenges infection control. Experts emphasize screening, isolation, environmental disinfection, and surveillance to reduce transmission among vulnerable hospitalized patients.

View Post

Mold News Candida Rnai Gene Silencing Micrograph

View Post

The Silencing Secret of Candida albicans: RNAi Is Back

RNA interference resurfaces in Candida albicans, overturning decades of assumptions about fungal gene control and pathogenic behavior.

View Post

View Post

New Blood Test Improves Detection of Invasive Mold Infections

A simple blood test can detect invasive mold infections early, helping doctors avoid risky biopsies and treat patients faster.

View Post

A new, super-terrifying fungus has been discovered.

View Post

Today’s news

Drug-Resistant Fungus Candida auris Detected in Connecticut as Experts Warn of Wider Presence

The multidrug-resistant fungus Candida auris has been detected in Connecticut, prompting renewed concern among infectious disease experts. This report examines why the fungus is considered a serious healthcare threat, how detection has expanded nationwide, transmission risks in medical facilities, and why surveillance data suggest broader presence.

View Post

View Post

Today’s news

Researchers Identify a Genetic Vulnerability in Candida auris, Opening New Paths for Antifungal Drug Development

A new scientific study has identified a key genetic weakness in Candida auris, a highly drug-resistant fungal pathogen. This report reviews the findings, explains the biological significance of the vulnerability, discusses implications for antifungal drug development, and outlines why this discovery matters for global health systems.

View Post